IGS-01

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameIGS-01
Drug Alias NameIGS01IGS-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDyskinesia, Drug-InducedParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIgnis Therapeutics (Suzhou) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesIgnis Therapeutics (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsDyskinesia, Drug-InducedParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A